Về công ty

Oligovax is a biopharmaceutical company focused on developing innovative therapies for cancer. Oligovax leads molecule, Litenimod, is potent agonist of toll Like receptor 9 (TLR9), triggering both innate and adaptive immune response.

FR
Không xác định
Chưa xác minh công ty